Gilead’s $7.8B acquisition of Arcellx boosts shares 78% amid push for new myeloma drug. Explore the deal, market impacts, and trading insights.

Valaris (VAL) shares close up 34.31% on news of a $5.8 billion all-stock acquisition by Transocean (RIG), creating a major offshore drilling powerhouse. Explore the deal’s implications and market lessons.

Listen up, folks! If you’re scanning the markets today, you’ve got...